Wahram Andrikyan

Professur für Arzneimitteltherapiesicherheit und Klinische Pharmakologie

Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in “Summaries of Product Characteristics” (2025) Andrikyan W, Sponfeldner M, Jung-Poppe L, Dürr P, Straubmeier MI, Schuster AK, Weisbach L, et al. Journal article Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC (2024) Sponfeldner M, Andrikyan W, Maas R, Fromm M Journal article Detection of Elevated Risk for Drug-Related Problems in the Hospital (2024) Jung-Poppe L, Pfistermeister B, Nicolaus H, Roggenhofer A, Altenbuchner A, Andrikyan W, Ströbel A, et al. Journal article Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients (2024) Andrikyan W, Sametinger SM, Kosfeld F, Jung-Poppe L, Fromm M, Maas R, Nicolaus H Journal article Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs (2023) Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, et al. Journal article, Original article Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data (2023) Andrikyan W, Jung-Poppe L, Altenbuchner A, Nicolaus HF, Pfistermeister B, Dormann H, Fromm M, Maas R Journal article, Original article POLAR-POLypharmacy, drug interActions and Risks-how can data from inpatient care support their assessment? (2022) Scherag A, Andrikyan W, Dreischulte T, Dürr P, Fromm M, Gewehr J, Jaehde U, et al. Journal article Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis (2022) Then M, Andrikyan W, Fromm M, Maas R Journal article Clarity, clinical applicability and relevance of absolute contraindications in official 'Summaries of Product Characteristics' (SmPCs) (2022) Andrikyan W, Then M, Dürr P, Jung-Poppe L, Schuster A, Weisbach L, Farker K, et al. Conference contribution Improved, but still limited coding of medication-related problems - application of the new WHO ICD-11 code-set to clinical routine data (2022) Jung-Poppe L, Andrikyan W, Altenbuchner A, Pfistermeister B, Dormann H, Fromm M, Maas R Conference contribution